ResultsIQ

ResultsIQ › Latest results › Amanta Healthcare Limited

Amanta Healthcare Limited Q4 FY26 results deck summary

NSE: AMANTA · BSE: 544502

Results deck of 19 May 2026, summarised by AI from the filing.

FY26 revenue ₹288 cr (+5% YoY), EBITDA ₹63 cr (+6.06% YoY) with 22% margin, PAT ₹15 cr (+42% YoY).

Key takeaways

  1. FY26 results FY26 revenue ₹288 cr (+5% YoY), EBITDA ₹63 cr (+6.06% YoY) with 22% margin, PAT ₹15 cr (+42% YoY).
  2. SteriPort expansion SteriPort capacity expansion to 11.6 cr bottles by FY27P, expected incremental revenue ₹110-120 cr per year.

Original filing on BSE

Amanta Healthcare Limited Q1 FY27 results

As filed: Revenue ₹68.8 cr (+6% year on year), EBITDA ₹14.5 cr (−3% year on year), PAT ₹3.3 cr (−17% year on year), EBITDA margin 21.1% (−194 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹77.0 cr, EBITDA ₹15.0 cr, PAT ₹5.5 cr, EBITDA margin 19.4%. Not scored. No result for the same quarter last year. Share price after the results: +18.4% in 30 days (Nifty 500: +3.3%).
  • Q3 FY26: Revenue ₹74.5 cr, EBITDA ₹15.4 cr, PAT ₹4.6 cr, EBITDA margin 20.6%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: −7.5%).
  • Q2 FY26: Revenue ₹71.0 cr, EBITDA ₹15.0 cr, PAT ₹1.0 cr, EBITDA margin 21.1%. Not scored. No result for the same quarter last year. Share price after the results: −15.9% in 30 days (Nifty 500: −0.6%).
  • Q1 FY26: Revenue ₹65.0 cr, EBITDA ₹15.0 cr, PAT ₹4.0 cr, EBITDA margin 23.1%. Not scored. No result for the same quarter last year. Share price after the results: −9.5% in 28 days (Nifty 500: +4.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Amanta Healthcare Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.